Myles Minter, Ph.D., who joined William Blair in October 2017, is an analyst covering biotechnology companies. Myles completed a postdoctoral appointment at the University of Chicago in the department of neurobiology working on the impact of the microbiome on Alzheimer's disease. He earned both a Ph.D., specializing in neuropharmacology, and a Bachelor of Biomedical Science degree from the University of Melbourne, Australia.
Year William Blair was founded
Independent and employee-owned
Companies under coverage
As of March 31, 2022
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.